CORP — CORPORATE / INDUSTRY

Gene therapy partnering routes (Rocket, Forge, Andelyn, AskBio)

Various gene therapy companies

Award

Partnership / subsidized AAV manufacturing

Deadline

Rolling business development

Award type

Partnership route

Focus

Preclinical & therapeutics

No company currently runs an open application program in this space. Rocket Pharmaceuticals has three clinical-stage inherited-cardiomyopathy AAV programs (PKP2-ACM, Danon, BAG3-DCM) and has originated programs from academic labs. Forge Biologics has subsidised manufacturing for patient-foundation programs, including the Progeria Research Foundation, and sits in the NIH Bespoke Gene Therapy Consortium. Andelyn Biosciences and AskBio are academic-adjacent AAV manufacturers.

Why it's in this index

BSF documents the AAV-TAZ preclinical science base, but no industry partner has been publicly named. These are the companies whose existing cardiomyopathy or foundation-partnership track record makes them the plausible approach.

Who can apply

Academic labs and foundations with gene-therapy programs seeking an industry partner or manufacturing.

How to apply

Engagement runs through business-development outreach and cardiology/gene-therapy congresses rather than portals.

Links & downloads

Rocket Pharma disease focus ↗Forge Biologics ↗BSF gene replacement overview ↗